Management of rectal neuroendocrine tumours by transanal endoscopic microsurgery
Colorectal Disease · 2023
DOI: 10.1111/codi.16506 ↗Kurz gefasst
Fachartikel in der Zeitschrift Colorectal Disease, 2023. Verfasst von Jessica J Lie und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of British Columbia, British Columbia, Vancouver, Canada. Hauptthemen laut MEDLINE: Transanal Endoscopic Microsurgery, Neuroendocrine Tumors, Rectal Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Aim
The objective of this study was to evaluate the safety and effectiveness of transanal endoscopic microsurgery for rectal neuroendocrine tumours.
Method
A retrospective cohort study of all pathology‐confirmed rectal neuroendocrine tumours treated by transanal endoscopic microsurgery from April 2007 to December 2020 at a tertiary care centre was performed. Demographic, clinical, radiographic and pathological data were collected. Characteristics of patients with recurrence were examined. Descriptive statistics were performed.
Results
There were 58 patients treated by transanal endoscopic microsurgery excision. Referrals were for primary excision (15, 25.9%), completion re‐excision after incomplete endoscopic removal (38, 65.5%) or locally recurrent rectal neuroendocrine tumours (5, 8.6%). The mean age of patients was 56.4 ± 11.9 years and 26 patients were women (44.8%). Mean tumour size was 7.4 ± 3.8 mm (range 1.0–15.0 mm). Most (86.4%) were Grade 1 tumours. Mean operative time was 37.2 ± 17.2 min and 56 patients (96.6%) were discharged on the same day. All patients had negative margins on final pathology. Of the 38 patients who were referred for completion re‐excision after incomplete endoscopic removal, eight (21.1%) had residual tumour on final pathology. Three recurrences were diagnosed at 2.1, 4.5 and 12.5 years after excision. All recurrences were from Grade 1 or 2 primary tumours, less than 2 cm, and diagnosed radiographically.
Conclusion
To date, this is the largest North American study looking at transanal endoscopic microsurgery for rectal neuroendocrine tumours. This technique is effective in managing primary, incompletely excised and recurrent tumours with good clinical and oncological outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, University of British Columbia, British Columbia, Vancouver, Canada.
- Harvard T.H. Chan School of Public Health, Massachusetts, Boston, USA.
- Department of Surgery, St Paul's Hospital, British Columbia, Vancouver, Canada.
- Department of Pathology and Laboratory Medicine, University of British Columbia, British Columbia, Vancouver, Canada.
ORCID-Profile: Jessica J Lie
Zitieren
APA
Lie, J. J., Yoon, H. M., Karimuddin, A. A., Raval, M. J., Phang, P. T., Ghuman, A., Lee, L. H., Stuart, H., & Brown, C. J. (2023). Management of rectal neuroendocrine tumours by transanal endoscopic microsurgery. Colorectal Disease. https://doi.org/10.1111/codi.16506
Vancouver
Lie JJ, Yoon HM, Karimuddin AA, Raval MJ, Phang PT, Ghuman A, et al. Management of rectal neuroendocrine tumours by transanal endoscopic microsurgery. Colorectal Disease. 2023. doi:10.1111/codi.16506
BibTeX
@article{Lie2023,
author = {Lie, Jessica J and Yoon, Hyea Min and Karimuddin, Ahmer A and Raval, Manoj J and Phang, P Terry and Ghuman, Amandeep and Lee, Lik Hang and Stuart, Heather and Brown, Carl J},
title = {Management of rectal neuroendocrine tumours by transanal endoscopic microsurgery},
journal = {Colorectal Disease},
year = {2023},
doi = {10.1111/codi.16506}
}
EUVIMED